Takeda Pharmaceutical Co ADR (TAK) concluded trading on Thursday at a closing price of $13.37, with 2.94 million shares of worth about $39.33 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -2.98% during that period and on May 09, 2024 the price saw a gain of about 2.37%. Currently the company’s common shares owned by public are about 3.14B shares, out of which, 3.14B shares are available for trading.
Stock saw a price change of 0.75% in past 5 days and over the past one month there was a price change of -1.47%. Year-to-date (YTD), TAK shares are showing a performance of -6.31% which decreased to -21.86% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $13.01 but also hit the highest price of $17.11 during that period. The average intraday trading volume for Takeda Pharmaceutical Co ADR shares is 1.64 million. The stock is currently trading 1.00% above its 20-day simple moving average (SMA20), while that difference is down -3.34% for SMA50 and it goes to -7.71% lower than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Takeda Pharmaceutical Co ADR (NYSE: TAK) currently have 3.14B outstanding shares and institutions hold larger chunk of about 5.57% of that.
The stock has a current market capitalization of $41.95B and its 3Y-monthly beta is at 0.58. PE ratio of stock for trailing 12 months is 33.43, while it has posted earnings per share of $0.40 in the same period. Its PEG reads 1671.67 and has Quick Ratio of 0.55 while making debt-to-equity ratio of 0.69. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for TAK, volatility over the week remained 1.64% while standing at 1.10% over the month.
Analysts are in expectations that Takeda Pharmaceutical Co ADR (TAK) stock would likely to be making an EPS of $0 in the current quarter, while forecast for next quarter EPS is $0.75 and it is $0.48 for next year. For the current quarter EPS, analysts have given the company a lowest target $0 which is $0 at the higher side of the target for the same. Stock’s fiscal year EPS is expected to rise by 29.79% while it is estimated to increase by 42.51% in next year. EPS is likely to grow at an annualized rate of 0.02% for next 5-years, compared to annual growth of -6.94% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by BofA Securities on March 16, 2023 offering a Buy rating for the stock and assigned a target price of $20 to it. Coverage by Cowen stated Takeda Pharmaceutical Co ADR (TAK) stock as an Outperform in their note to investors on July 19, 2022, suggesting a price target of $24 for the stock. Stock get a Market perform rating from Cowen on November 01, 2019.
